In silico Screening and in vitro Cytotoxicity Study of Achyranthes aspera Phytochemicals Against Oral Cancer: A Possible Step towards the Development of Anti-cancer Agents

被引:0
|
作者
Israr, Juveriya [1 ,2 ]
Khan, Mohsin Ali [3 ]
Misra, Sankalp [1 ]
Gupta, Divya [1 ,4 ]
Singh, Nootan [1 ]
Ahmad, Rumana [5 ]
Siddiqui, Sahabjada [2 ]
机构
[1] Shri Ramswaroop Mem Univ, Inst Biosci & Technol, Fac Biosci, Lucknow Deva Rd, Barabanki, India
[2] Era Univ, Dept Biotechnol, Lucknow, India
[3] Era Univ, Eras Lucknow Med Coll & Hosp, Res & Dev Unit, Lucknow, India
[4] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA USA
[5] Era Univ, Eras Lucknow Med Coll & Hosp, Dept Biochem, Lucknow, India
关键词
Oral squamous cell carcinoma; cytotoxicity; Akt1; Akt2; Achyranthes aspera; phytoconstituents; molecular docking; DRUG-LIKENESS; ISOFORMS; DOCKING; ADMET; LEADS;
D O I
10.2174/0113862073289916240503051643
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Oral cancer poses a significant threat to public health worldwide. In addition, because many chemotherapy treatments have negative side effects, natural herbs may be beneficial for oral cancer therapy. Achyranthes aspera (AA), a potential medicinal herb, exerts various pharmacological and biochemical activities. Objective The present study aimed to predict the anti-oral cancer potential of AA using in silico tools and cell death by in vitro testing. Methods A total of fourteen bioactive constituents from AA herb were selected using phytochemical databases. The toxicity of AA herb extract was analysed through MTT assay against oral carcinoma A253 cell line. The binding activities of the phytocomponents against serine/threonine-specific protein kinases isoforms, namely Akt1 (PDB ID: 3qkk) and Akt2 (PDB ID: 2jdo) proteins, were analysed using Discovery Studio 2021 and PyRx docking software. Results Cell viability data revealed that AA extract decreased the viability and reduced the number of live cells of the oral carcinoma A253 cell line in a dose-dependent manner. The half-maximal concentration (IC50) value of AA was assessed as 204.74 mu g/ml. Based on binding affinity, saponin C (-CDOCKER energy = -77.9862 Kcal/mol), oleanolic acid (-CDOCKER energy = -49.4349 Kcal/mol), spinasterol (-CDOCKER energy = -38.1246 Kcal/mol), 36,47-dihydroxyhenpentacontan-4-one (-CDOCKER energy = -32.4386 Kcal/mol), and 20-hydroxyecdysone (-CDOCKER energy = -31.9138 Kcal/mol) were identified as the best compounds against Akt1, while, compounds saponin C (-CDOCKER energy = -134.412 Kcal/mol), oleanolic acid (-CDOCKER energy = -90.0846 Kcal/mol), spinasterol (-CDOCKER energy = -78.3213 Kcal/mol), 20-hydroxyecdysone (-CDOCKER energy = -80.1049 Kcal/mol), and ecdysone (-CDOCKER energy = -73.3885 Kcal/mol) were identified as Akt2 inhibitors. These top compounds fulfilled drug score values, pharmacokinetic and physicochemical characteristics, and drug-likeness parameters. Conclusion The present findings reveal that the lead phytomolecules of AA could be effective and developed as a prospective drug against oral cancer.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Synthesis and in vitro cytotoxicity of novel C-12 substituted-14-deoxy-andrographolide derivatives as potent anti-cancer agents
    Kandanur, Sai Giridhar Sarma
    Golakoti, Nageswara Rao
    Nanduri, Srinivas
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (24) : 5781 - 5786
  • [32] Exploring the Anti-Cancer Potential of Hispidin: A Comprehensive in Silico and in Vitro Study on Human Osteosarcoma Saos2 Cells
    Benarous, Khedidja
    Serseg, Talia
    Mermer, Arif
    Tahmasebifar, Aydin
    Boulebd, Houssem
    Linani, Abderahmane
    CHEMISTRY & BIODIVERSITY, 2024, 21 (05)
  • [33] Oxovanadium(IV) complexes of 1,10-phenanthroline are potent anti-cancer agents against human testicular cancer cell lines in vitro.
    D'Cruz, OJ
    Dong, YH
    Uckun, FM
    CLINICAL CANCER RESEARCH, 1999, 5 : 3786S - 3787S
  • [34] An in silico study: Searching for potential anti-cancer agents from Xanthone derivatives targeting Topoisomerase II-alpha protein
    Nguyen, Hang N. T.
    Thi, Hong Minh Pham
    Van, Huyen Luu
    Thi, Thuy Huong Le
    Pham, Minh Quan
    Dao, Huy Toan
    2023 1ST INTERNATIONAL CONFERENCE ON HEALTH SCIENCE AND TECHNOLOGY, ICHST 2023, 2023,
  • [35] In Silico Screening for Novel Tyrosine Kinase Inhibitors with Oxindole Scaffold as Anti-Cancer Agents: Design, QSAR Analysis, Molecular Docking and ADMET Studies
    Zangeneh, Jalalaldin
    Shirvani, Pouria
    Etebari, Mahmoud
    Saghaie, Lotfollah
    JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2022, 21 (05): : 583 - 598
  • [36] Development, validation and pilot screening of an in vitro multi-cellular three-dimensional cancer spheroid assay for anti-cancer drug testing
    Lama, Rati
    Zhang, Lin
    Naim, Janine M.
    Williams, Jennifer
    Zhou, Aimin
    Su, Bin
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (04) : 922 - 931
  • [37] Screening and Development of Transglutaminase-2 Inhibitors and their Derivative as Anti-lung Cancer Agent by in silico and in vitro Approaches
    Parvatikar, Prachi P.
    Patil, Sumangala
    Hoskeri, Joy
    Swargam, Sandeep
    Kulkarni, Raghvendra, V
    Das, Kusal K.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2022, 18 (01) : 41 - 51
  • [38] Developing FGFR4 Inhibitors As Potential Anti-Cancer Agents Via In Silico Design, Supported by In Vitro and Cell-Based Testing
    Ho, H. K.
    Nemeth, G.
    Ng, Y. R.
    Pang, E.
    Szantai-Kis, C.
    Zsakai, L.
    Breza, N.
    Greff, Z.
    Horvath, Z.
    Pato, J.
    Szabadkai, I.
    Szokol, B.
    Baska, F.
    Orfi, L.
    Ullrich, A.
    Keri, G.
    Chua, B. T.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (10) : 1203 - 1217
  • [39] In Silico and In Vitro Evaluations of Fluorophoric Thiazolo-[2,3-b]quinazolinones as Anti-cancer Agents Targeting EGFR-TKD
    Mir, Showkat Ahmad
    Dash, Ganesh Chandra
    Meher, Rajesh Kumar
    Mohanta, Prajna Parimita
    Chopdar, Kumar Sambhav
    Mohapatra, Pranab Kishor
    Baitharu, Iswar
    Behera, Ajaya Kumar
    Raval, Mukesh Kumar
    Nayak, Binata
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2022, 194 (10) : 4292 - 4318
  • [40] Design and development of novel docetaxel -loaded DQAsomes for inducing apoptosis and anti-cancer effect on the breast cancer cells, an in vitro study
    Pawar, Abhishek
    Kamble, Ravindra
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 73